FIRMAGON® - Advanced Prostate Cancer Treatment

Tags:: Firmagon Prostate Cancer Health Medicine

Edit Video Details

By: AKAmedia
Subscribers: 1
Updated: 28-Oct-09
Videos: 30

Basic English
Comments: 0
Views: 202
Added: 07-Aug-09

FIRMAGON® (degarelix for injection), a new injectable prostate cancer medication for the treatment of advanced prostate cancer, is now available in the U.S. The treatment rapidly inhibits the production of testosterone, a hormone that stimulates cancer growth. FIRMAGON was approved by the U.S. Food and Drug Administration (FDA) on December 24, 2008 and was granted marketing authorization by the European Commission on February 19, 2009. It was launched in the U.S. in March 2009 under the generic name, degarelix.